Mungo, Irene Chemtai |
Univ Of North Carolina Chapel Hill
United States |
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs |
5R34CA284983-02 |
|
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Mustian, Karen M. |
University Of Rochester
United States |
URCC NCORP Research Base |
5UG1CA189961-11 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Muzumdar, Mandar Deepak |
Yale University
United States |
Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics |
1R01CA296916-01 |
|
|
Mwesigwa, Betty |
Makerere University Walter Reed Project
United States |
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) |
5UG1CA275412-03 |
|
Maria Silvina Frech, Ph.D., M.S. |
Nabavi, Sheida |
University Of Connecticut Storrs
United States |
SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening |
1R01CA297855-01 |
|
Claire Zhu, Ph.D. |
Naicker, Nivashnee |
Centre/Aids Programme/Res/South Africa
United States |
CAPRISA CASCADE Clinical Trials Network Clinical Research Site |
5UG1CA284671-02 |
|
Maria Silvina Frech, Ph.D., M.S. |
Nappi, Lucia |
Provincial Health Services Authority
United States |
Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. |
5R37CA264798-03 |
PAR-19-264 (R01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
Nath, Kavindra |
University Of Pennsylvania
United States |
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition |
5R01CA228457-05 |
|
|
Nechiporuk, Alex |
Oregon Health & Science University
United States |
High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies. |
1R21CA260025-01A1 |
|
Rachel Altshuler, Ph.D. |
Nelson, Randy J. |
West Virginia University
United States |
Mechanism Underlying Sleep Disruption by Mammary Tumors |
5R21CA276027-02 |
|
Marjorie Perloff, M.D. |